Protagonist, Ironwood expand drug discovery deal

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2012

Singapore: Protagonist Therapeutics and Ironwood Pharmaceuticals are expanding their research collaboration. The collabo...Read more

Admedus acquires Genzyme manufacturing site

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufact...Read more

UBI flourishes in diagnostics by collaboration

Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

Universal Biosensors (UBI) is a medical diagnostics company focused on the R&D and manufacture of diagnostic test sy...Read more

Stemtech enters into exclusive deal with Marinova

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

Singapore: Stemtech International, a pioneer in stem cell nutrition, has signed an exclusive business deal with Marinova...Read more

GE invests in infection control technology

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2012

Singapore: Global healthcare company GE has invested $7.5 million in Australia-based Nanosonics, a leader in the develop...Read more

Mindray acquires its former Aus distributor Ulco

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: Mindray Medical International has acquired Australia-based former distributor of Mindray, Ulco Medical. Ulco...Read more

Novartis infant meningococcal vaccine gets FDA nod

Australia |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 02 Aug, 2013

Singapore: The US FDA has approved Novartis' Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine) for the p...Read more

Clinical trials for Prima BioMed's CVacâ„¢ extended

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Prima BioMed, Australia's leading biotechnology company pioneering in therapeutic area of cancer is said to b...Read more

US, Aus firms to commercialize cancer drug

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

Singapore: Australian drug giant Maybe Pharma Group has announced its signing of an exclusive supply and license agreeme...Read more

CSL renames 2 of its businesses in Australia

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

Singapore: CSL's plasma product operations in Australia will take on the name of its global plasma business, CSL Behring...Read more

What were Asia's Top 20 bio companies in 2012?

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...Read more

BioDiem gets positive results for eye disease drug

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from ...Read more

Quality researchers give an edge to Australia

Australia |  Opinion | By BioSpectrum Bureau  | 4 Comment | 13 Sep, 2013

Australia, known for providing rigorous high quality clinical research and enthusiastic investigators with centers of ...Read more

Alchemia provides update on its core projects

Australia |  Company results | By BioSpectrum Bureau  | 4 Comment | 22 May, 2013

Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed d...Read more

Australia strengthens scientific collaboration with Indonesia

Australia |  Influencers | By BioSpectrum Bureau  | 3 Comment | 24 Apr, 2014

Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understa...Read more

Bluechiip industry solution trial proves successful

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jun, 2012

Singapore: Australia company Bluechiip, which has developed a unique asset-tracking solution initially for cryogenic sam...Read more

ABRAXANE phase III trial shows improved results

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

Singapore: A phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitax...Read more

AusBiotech appoints new directors

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: At the company's annual general meeting in Brisbane last week, AusBiotech announced the appointment of two ne...Read more